# | ||||
---|---|---|---|---|
1 | VAC2VAC Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 | 2016 | 16˙290˙929.00 | 7˙850˙000.00 |
2 | ZIKAVAX Fast track development of a Zika vaccine based on measles vector | 2016 | 4˙918˙137.00 | 4˙918˙137.00 |
3 | TRANSVAC2 European Vaccine Research and Development Infrastructure | 2017 | 10˙599˙993.00 | 10˙599˙993.00 |
4 | SHIGETECVAX Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | 2019 | 0.00 | 8˙603˙989.00 |
The Institution EUROPEAN VACCINE INITIATIVE EWIV has been involved also in the following Horizon 2020 projects.